BiotechTube
Home/Etcembly/Nick Cross
NC

Nick Cross

Chairman

Etcembly

Therapeutic Areas

OncologyImmunology

Etcembly Pipeline

DrugIndicationPhase
Zelluna TCR-NK Candidate (Platform-Optimized)Not Specified (Likely Oncology)Pre-clinical

Leadership Team at Etcembly

MT
Michelle Teng
CEO & Co-founder
JH
Jacob Hurst
CTO & Co-founder
NP
Nick Pumphrey
CSO
JM
John McCafferty
Scientific Advisor
View full Etcembly profile